171 related articles for article (PubMed ID: 165031)
1. Vitamin D metabolism and parathyroid function in man.
Mawer EB; Backhouse J; Hill LF; Lumb GA; De Silva P; Taylor CM; Stanbury SW
Clin Sci Mol Med; 1975 May; 48(5):349-65. PubMed ID: 165031
[TBL] [Abstract][Full Text] [Related]
2. The metabolism of a physiological dose of radioactive cholecalciferol (vitamin D3) to its hydroxylated metabolites in man.
Stanbury SW; Mawer EB
Clin Sci (Lond); 1980 Jun; 58(6):523-35. PubMed ID: 6253118
[TBL] [Abstract][Full Text] [Related]
3. Influence of cadmium on the metabolism of vitamin D3 in rats.
Ando M; Shimizu M; Matsui S; Sayato Y; Takeda M
Toxicol Appl Pharmacol; 1987 Jun; 89(2):158-64. PubMed ID: 3037727
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in our understanding of the vitamin D endocrine system.
De Luca HF
J Lab Clin Med; 1976 Jan; 87(1):7-26. PubMed ID: 173767
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. 1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.
Berl T; Berns AS; Hufer WE; Hammill K; Alfrey AC; Arnaud CD; Schrier RW
Ann Intern Med; 1978 Jun; 88(6):774-80. PubMed ID: 208439
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D metabolites and bone mineralization in man.
Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.
Brossard JH; Garon J; Lepage R; Gascon-Barré M; D'Amour P
Bone Miner; 1993 Oct; 23(1):15-26. PubMed ID: 8274876
[TBL] [Abstract][Full Text] [Related]
9. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Mortensen BM; Gautvik KM; Gordeladze JO
Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of vitamin D: current status.
DeLuca HF
Am J Clin Nutr; 1976 Nov; 29(11):1258-70. PubMed ID: 187053
[TBL] [Abstract][Full Text] [Related]
11. Controlled trial of the effects of 1,25-dihydroxycholecalciferol in patients treated with regular dialysis.
Berl T; Berns AS; Huffer WE; Alfrey AC; Arnaud CD; Schrier RR
Contrib Nephrol; 1980; 18():72-81. PubMed ID: 6243528
[TBL] [Abstract][Full Text] [Related]
12. The kidney as an endocrine organ involved in the function of vitamin D.
DeLuca HF
Am J Med; 1975 Jan; 58(1):39-47. PubMed ID: 163578
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of 1,25-dihydroxyvitamin D3.
Kumar R
Physiol Rev; 1984 Apr; 64(2):478-504. PubMed ID: 6324253
[TBL] [Abstract][Full Text] [Related]
14. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
15. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
[TBL] [Abstract][Full Text] [Related]
16. Aminoaciduria in chronic renal failure--its relationship to vitamin D and parathyroid status.
Phillips ME; Havard J; Otterud B
Am J Clin Nutr; 1980 Jul; 33(7):1541-5. PubMed ID: 6893104
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in Osteoporosis.
Davies M; Mawer EB; Adams PH
J Clin Endocrinol Metab; 1977 Aug; 45(2):199-208. PubMed ID: 195972
[TBL] [Abstract][Full Text] [Related]
18. Effects of vitamin D3, 25-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion.
Cantley LK; Russell JB; Lettieri DS; Sherwood LM
Calcif Tissue Int; 1987 Jul; 41(1):48-51. PubMed ID: 3040201
[TBL] [Abstract][Full Text] [Related]
19. Decreased renal function in association with administration of 1,25-dihydroxyvitamin D3 to patients with stable, advanced renal failure.
Christiansen C; Røodbro P; Christensen MS; Naestoft J; Hartnack B; Transbøol I
Contrib Nephrol; 1980; 18():139-46. PubMed ID: 6243527
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
Gonzalez-Villapando C; Porath A; Berelowitz M; Marshall L; Favus MJ
J Clin Endocrinol Metab; 1980 Nov; 51(5):1180-3. PubMed ID: 6893459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]